{
  "format": "healthspanledger-research-release-ledger",
  "schemaVersion": 1,
  "dataset": {
    "id": "clinicaltrials-pipeline",
    "name": "Registered clinical trials by peptide and GLP-1 compound",
    "canonicalUrl": "https://healthspanledger.com/pipeline"
  },
  "releases": [
    {
      "edition": "2026.08",
      "version": "4a66223f5f00",
      "retrieved": "2026-08-14",
      "sourceUpdated": null,
      "rowCount": 33,
      "note": "First recorded public release of the compound-level trial census."
    },
    {
      "edition": "2026.08",
      "version": "be9f4bffd80b",
      "retrieved": "2026-08-16",
      "sourceUpdated": null,
      "rowCount": 34,
      "note": "Added VK2735 to the compound-level trial census and refreshed every registered-study count."
    },
    {
      "edition": "2026.08",
      "version": "150bbe9347b4",
      "retrieved": "2026-08-17",
      "sourceUpdated": null,
      "rowCount": 36,
      "note": "Added Zenagamtide and Pemvidutide to the trial census, refreshed the complete monitored scope, and excluded six unrelated oncology registrations captured by the reused ALT-801 code."
    },
    {
      "edition": "2026.08",
      "version": "13e69b7fe32e",
      "retrieved": "2026-08-17",
      "sourceUpdated": null,
      "rowCount": 36,
      "note": "Refreshed the complete trial census; added four new registrations across Semaglutide, Survodutide and Mazdutide, and recorded Pemvidutide registry status, enrollment and completion-date changes."
    },
    {
      "edition": "2026.08",
      "version": "198288fe6fa4",
      "retrieved": "2026-08-23",
      "sourceUpdated": null,
      "rowCount": 36,
      "note": "Refreshed the complete trial census; added eight identity-checked registrations and recorded five registry status, enrollment or completion-date movements without changing fixed clinical claims."
    }
  ]
}